BMJ
- SAXENA S, Skirrow H, Maini A, Hayhoe B, et al
Consenting children aged under 18 for vaccination and treatment.
BMJ. 2022;377:e068889.
- HITCHINGS MDT, Ranzani OT, Lind ML, Dorion M, et al
Change in covid-19 risk over time following vaccination with CoronaVac: test
negative case-control study.
BMJ. 2022;377:e070102.
- MAZZILLI S, Moazen B, Stover H, Plugge E, et al
Covid-19 vaccine in prison: a not-to-be-missed opportunity to promote access to
vaccination in adolescents.
BMJ. 2022;377:o1439.
Clin Infect Dis
- MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron
infection in individuals previously infected by other variants.
Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
- LIM SY, Park S, Kim JY, Kim S, et al
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant
6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19
Vaccination) Versus 2-dose COVID-19 Vaccination.
Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
- RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2
Exposure-Minnesota, January-August 2021.
Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
- BUSCH MP, Stramer SL, Stone M, Yu EA, et al
Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and
hybrid immunity among U.S. blood donations from January-December 2021.
Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
- LI ZN, Liu F, Jefferson S, Horner L, et al
Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human
Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
- TOP KA, Chen RT, Levy O, Ozonoff A, et al
Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond:
Launching an International Network of Special Immunization Services.
Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
J Immunol
- NAGASHIMA K, Dzimianski JV, Han J, Abbadi N, et al
The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza
H1 Hemagglutinin Vaccines.
J Immunol. 2022 Jun 13. pii: jimmunol.2101171. doi: 10.4049/jimmunol.2101171.
J Infect
- WORSLEY CM, van der Mescht MA, Hoffman D, Meyer PWA, et al
Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to
health care workers.
J Infect. 2022 Jun 12. pii: S0163-4453(22)00360.
- KANG SW, Kim JY, Park H, Lim SY, et al
Comparison of outward transmission potential between vaccinated and partially
vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant
infection.
J Infect. 2022 Jun 12. pii: S0163-4453(22)00355.
- XU QY, Li QL, Jia ZJ, Wu MJ, et al
Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a
prospective cohort study.
J Infect. 2022 Jun 9. pii: S0163-4453(22)00356.
- JIMENEZ D, Martinez-Sanz J, Sainz T, Calvo C, et al
Differences in saliva ACE2 activity among infected and non-infected adult and
pediatric population exposed to SARS-CoV-2.
J Infect. 2022 Apr 28. pii: S0163-4453(22)00248.
- SALVAGNO GL, Henry BM, Pighi L, De Nitto S, et al
Serum C reactive protein predicts humoral response after BNT162b2 booster
administration.
J Infect. 2022 Apr 8. pii: S0163-4453(22)00197.
J Infect Dis
- SIEDNER MJ, Alba C, Fitzmaurice KP, Gilbert RF, et al
Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries.
J Infect Dis. 2022 Jun 13. pii: 6606162. doi: 10.1093.
J Virol
- OLCZAK P, Matsui K, Wong M, Alvarez J, et al
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human
Papillomaviruses Causing Human Cancer.
J Virol. 2022 Jun 15:e0056622. doi: 10.1128/jvi.00566.
- SUN C, Yuan RY, Xie C, Sun JF, et al
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by
S1 Nanoparticle Vaccines.
J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
- VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
- TU JJ, Kumar A, Giorgi EE, Eudailey J, et al
Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody
Responses.
J Virol. 2022 May 10:e0023122. doi: 10.1128/jvi.00231.
JAMA
- LARKIN HD
Maternal RSV Vaccine Could Protect Infants, Interim Analysis Suggests.
JAMA. 2022;327:2182.
- JONES JM, Opsomer JD, Stone M, Benoit T, et al
Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates
Based on Blood Donations, July 2020-December 2021.
JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
- LI Y
Characteristics and Outcomes of Hospitalized Patients in South Africa During the
COVID-19 Omicron Wave.
JAMA. 2022;327:2147-2148.
Lancet
- LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children
aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind,
randomised, controlled trial.
Lancet. 2022;399:2212-2225.
- WONG HL, Hu M, Zhou CK, Lloyd PC, et al
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the
USA: a cohort study in claims databases.
Lancet. 2022;399:2191-2199.
- PATEL M, Patel M
Increasing children's global access to COVID-19 vaccines.
Lancet. 2022;399:2171-2173.
- HUSBY A, Kober L
COVID-19 mRNA vaccination and myocarditis or pericarditis.
Lancet. 2022;399:2168-2169.
MMWR Morb Mortal Wkly Rep
- DAVLANTES E
Notes from the Field: Initial Outbreak Response Activity Following Wild
Poliovirus Type 1 Detection - Malawi, February 2022.
MMWR Morb Mortal Wkly Rep. 2022;71:776-777.
N Engl J Med
- GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.
N Engl J Med. 2022 May 25. doi: 10.1056/NEJMoa2118946.
- ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
- MATUCHANSKY C
Protection against SARS-CoV-2 after Vaccination and Previous Infection.
N Engl J Med. 2022;386.
- HOPKINS S, Hall V, Klenerman P
Protection against SARS-CoV-2 after Vaccination and Previous Infection. Reply.
N Engl J Med. 2022;386.
- LEUCHTER RK, Jackson NJ, Mafi JN, Sarkisian CA, et al
Association between Covid-19 Vaccination and Influenza Vaccination Rates.
N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMc2204560.
Pediatr Infect Dis J
- KOENRAADS M, Swarthout TD, Bar-Zeev N, Brown C, et al
Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days
of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate
Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study.
Pediatr Infect Dis J. 2022 Jun 13. pii: 00006454-990000000-00099.
- PLOTKIN S
Serologic Tests for COVID-19 Infections and Vaccination.
Pediatr Infect Dis J. 2022 Jun 14. pii: 00006454-990000000-00102.
- BURNETT E, Parashar UD, Winn A, Curns AT, et al
Major Changes in Spatiotemporal Trends of US Rotavirus Laboratory Detections
After Rotavirus Vaccine Introduction-2009-2021.
Pediatr Infect Dis J. 2022 Jun 1. pii: 00006454-990000000-00087.
- BIJKER EM, Bateman EAL, Truck J, Patel S, et al
Screening for Immunodeficiencies in Children With Invasive Pneumococcal Disease:
Six-year Experience From a UK Children's Hospital.
Pediatr Infect Dis J. 2022;41:575-578.
PLoS Med
- MARTIN CA, Pan D, Melbourne C, Teece L, et al
Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of
United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
PLoS Med. 2022;19:e1004015.
PLoS One
- PAWASKAR M, Fergie J, Harley C, Samant S, et al
Impact of universal varicella vaccination on the use and cost of antibiotics and
antivirals for varicella management in the United States.
PLoS One. 2022;17:e0269916.
- KOBASHI Y, Shimazu Y, Kawamura T, Nishikawa Y, et al
Factors associated with anti-severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) spike protein antibody titer and neutralizing activity among
healthcare workers following vaccination with the BNT162b2 vaccine.
PLoS One. 2022;17:e0269917.
- RANGELOVA V, Raycheva R, Sariyan S, Kevorkyan A, et al
Reporting adverse events of COVID-19 vaccines: The case of Bulgaria.
PLoS One. 2022;17:e0269727.
- PAPANEOPHYTOU C, Nicolaou A, Pieri M, Nicolaidou V, et al
Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus.
PLoS One. 2022;17:e0269885.
- RANI MDM, Mohamed NA, Solehan HM, Ithnin M, et al
Assessment of acceptability of the COVID-19 vaccine based on the health belief
model among Malaysians-A qualitative approach.
PLoS One. 2022;17:e0269059.
- GU M, Taylor B, Pollack HA, Schneider JA, et al
A pilot study on COVID-19 vaccine hesitancy among healthcare workers in the US.
PLoS One. 2022;17:e0269320.
- BOHN-GOLDBAUM E, Owen KB, Lee VYJ, Booy R, et al
Physical activity and acute exercise benefit influenza vaccination response: A
systematic review with individual participant data meta-analysis.
PLoS One. 2022;17:e0268625.
- DE ANDRADE PEREIRA SILVA M, Ribeiro HF, Oliveira RR, Pelloso FC, et al
Factors associated with vaccination against Covid-19 in pregnant and hospitalized
postpartum women: A retrospective cohort study.
PLoS One. 2022;17:e0269091.
- MA Y, Zhao Y, Chen R, Sun W, et al
Mucosal immunity of mannose-modified chitosan microspheres loaded with the
nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
PLoS One. 2022;17:e0269153.
Vaccine
- DIAZ-MENENDEZ M, de la Calle-Prieto F, Montejano R, Arsuaga M, et al
Clinical characteristics and outcome of hospitalized elderly patients with COVID-
19 after vaccine failure.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00751.
- SHOOTS-REINHARD B, Lawrence ER, Schulkin J, Peters E, et al
Excluding numeric side-effect information produces lower vaccine intentions.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00747.
- DAYTON L, Miller J, Strickland J, Davey-Rothwell M, et al
A socio-ecological perspective on parents' intentions to vaccinate their children
against COVID-19.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00736.
- EL-SHESHENY R, El Taweel A, Gomaa MR, Roshdy WH, et al
Induced humoral immunity of different types of vaccines against most common
variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00734.
- SHANMUGARAJ B, Khorattanakulchai N, Panapitakkul C, Malla A, et al
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective
efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00735.
- ROLLIER CS, Dold C, Blackwell L, Linder A, et al
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after
childhood immunisation.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00539.
- ZHAO FJ, Liu LT, Wang Z, Wang NX, et al
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated
vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
- HASHIMOTO M, Nagata N, Homma T, Maeda H, et al
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein
vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
- EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or
heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
- HALME J, Syrjanen RK, Baum U, Palmu AA, et al
Effectiveness of trivalent influenza vaccines against hospitalizations due to
laboratory-confirmed influenza a in the elderly: Comparison of test-negative
design with register-based designs.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00716.
- SLARVE M, Holznecht N, Reza H, Gilkes A, et al
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal
vaccine protect mice against invasive pulmonary aspergillosis.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00674.
- FLYNN JA, Weber T, Cejas PJ, Cox KS, et al
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines
expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman
primates.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00382.
- SLOTTE P, Karlsson LC, Soveri A
Attitudes towards mandatory vaccination and sanctions for vaccination refusal.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00697.
- SMITH WJ, Ahl PL, Wang B, Hamm M, et al
Analytical technology development to monitor the stability of
Polysaccharide-Protein conjugate vaccines.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00673.
- OKUNO H, Satoh H, Morino S, Arai S, et al
Characteristics and incidence of vaccine adverse events after Bacille
Calmette-Guerin vaccination: A national surveillance study in Japan from 2013 to
2017.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00672.
- CHICHILI GR, Smulders R, Santos V, Cywin B, et al
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged
18 to 64 years and in older adults aged 65 to 85 years.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00715.
- LIGHTOWLER MS, Manangazira P, Nackers F, Van Herp M, et al
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an
outbreak among children and young adults: A matched case control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00552.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016